Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate

Follow Us

News Trending Portfolio

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

STOCKS

Plans & Pricing

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Best Healthcare & Medical Stocks

Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.

Compare up to 10 stocks

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Smart Score	Market Cap	P/E Ratio	Dividend Yield	Sector	Article	Follow
PFE Pfizer	$25.61	4.15M	xxxxxxxxxxxxx	7 Buy 12 Hold 1 Sell Moderate Buy		$142.41B	33.78	6.70%	Healthcare
NVS Novartis	$105.03	176.08K	xxxxxxxxxxxxx	0 Buy 6 Hold 0 Sell Hold		$204.58B	12.03	3.10%	Healthcare
JNJ Johnson & Johnson	$156.99	775.19K	xxxxxxxxxxxxx	6 Buy 8 Hold 0 Sell Moderate Buy		$374.39B	25.70	3.17%	Healthcare
RHHBY Roche Holding	$35.62	36.31K	xxxxxxxxxxxxx	0 Buy 3 Hold 0 Sell Hold		$228.49B	18.82	2.41%	Healthcare
ABT Abbott Laboratories	$117.12	399.67K	xxxxxxxxxxxxx	17 Buy 3 Hold 0 Sell Strong Buy		$203.38B	35.66	1.90%	Healthcare
LLY Eli Lilly & Co	$753.36	595.79K	xxxxxxxxxxxxx	17 Buy 1 Hold 0 Sell Strong Buy		$711.91B	82.03	0.67%	Healthcare
CVS CVS Health	$57.13	619.52K	xxxxxxxxxxxxx	11 Buy 4 Hold 0 Sell Moderate Buy		$71.86B	14.51	4.68%	Healthcare
UNH UnitedHealth	$597.02	280.69K	xxxxxxxxxxxxx	18 Buy 1 Hold 0 Sell Strong Buy		$549.86B	38.81	1.32%	Healthcare
TDOC Teladoc	$10.49	1.24M	xxxxxxxxxxxxx	6 Buy 13 Hold 0 Sell Moderate Buy		$1.79B	-1.80	―	Healthcare

Performance Comparison

PFE

Pfizer

25.13

-3.44

-12.04%

NVS

Novartis

103.85

9.08

9.58%

JNJ

Johnson & Johnson

155.50

8.14

5.52%

RHHBY

Roche Holding

35.29

2.79

8.58%

ABT

Abbott Laboratories

117.26

16.57

16.46%

LLY

Eli Lilly & Co

749.92

158.69

26.84%

CVS

CVS Health

57.10

-9.26

-13.95%

UNH

UnitedHealth

597.49

61.89

11.56%

TDOC

Teladoc

10.40

-6.65

-39.00%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Trump expected to pick Martin Makary to head FDA, Reuters reports

Trump expected to pick Martin Makary to head FDA, Reuters reports

Johns Hopkins surgeon and writer Martin Makary is expected to be selected by President-elect Donald Trump to head...

24m ago

JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya

JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya

Johnson & Johnson announced the submission of a supplemental Biologics License Application to the U.S. FDA seeking approval...

2h ago

Protagonist Therapeutics price target raised to $67 from $51 at BTIG

Protagonist Therapeutics price target raised to $67 from $51 at BTIG

BTIG raised the firm’s price target on Protagonist Therapeutics (PTGX) to $67 from $51 and keeps a Buy...

3h ago

HIMS Stock Surges after Court Case with Eli Lilly Gets Put on Hold

HIMS Stock Surges after Court Case with Eli Lilly Gets Put on Hold

Shares of healthcare company Hims & Hers Health ($HIMS) surged on Thursday after a Texas court temporarily paused...

17h ago

FDA tirzepatide status report ‘moderately positive’ for Hims & Hers, says Citi

FDA tirzepatide status report ‘moderately positive’ for Hims & Hers, says Citi

Citi notes that the FDA said in a status report filed in a Texas court that it needs...

18h ago

Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s

Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s

A joint status report that was filed in the U.S. District Court for the Northern District of Texas...

19h ago

Trump Trade: Transition team weighing White House crypto role

Trump Trade: Transition team weighing White House crypto role

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

22h ago

FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera

FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera

The Food and Drug Administration granted accelerated approval to zanidatamab-hrii, or Ziihera from Jazz Pharmaceuticals (JAZZ), Inc., a...

23h ago

Novartis Guidance Upgrade Fails to Impress Shareholders

Novartis Guidance Upgrade Fails to Impress Shareholders

Novartis announced an upgrade for its sales CAGR today but investors don’t seem overly impressed by the company’s news. ...

23h ago

Teladoc call volume above normal and directionally bullish

Teladoc call volume above normal and directionally bullish

Bullish option flow detected in Teladoc (TDOC) with 22,066 calls trading, 6x expected, and implied vol increasing over...

23h ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Healthcare Stocks

Teladoc

Hold

Reiterated

2024-11-21

Pfizer

Hold

Assigned

2024-11-20

CVS Health

Buy

Reiterated

2024-11-20

Eli Lilly & Co

Buy

Reiterated

2024-11-20

Johnson & Johnson

Hold

Reiterated

2024-11-19

Abbott Laboratories

Buy

Reiterated

2024-11-19

Novartis

Hold

Downgraded

2024-11-19

UnitedHealth

Buy

Assigned

2024-11-18

Roche Holding

Hold

Downgraded

2024-11-05

Johnson & Johnson

Buy

Reiterated

2024-11-19

Most Recent Earnings of Healthcare Stocks

Pfizer

Oct 29, 2024

Sep 01, 2024

0.61 / 1.06

0.1

Novartis

Oct 29, 2024

Sep 01, 2024

1.94 / 2.06

1.53

Johnson & Johnson

Oct 15, 2024

Sep 01, 2024

2.21 / 2.42

2.29

Roche Holding

Jul 25, 2024

Jun 01, 2024

1.30 / 1.43

1.229

Abbott Laboratories

Oct 16, 2024

Sep 01, 2024

1.20 / 1.21

1.19

Eli Lilly & Co

Oct 30, 2024

Sep 01, 2024

1.42 / 1.18

2.49

CVS Health

Nov 06, 2024

Sep 01, 2024

1.44 / 1.09

2.12

UnitedHealth

Oct 15, 2024

Sep 01, 2024

7.00 / 7.15

6.16

Teladoc

Oct 30, 2024

Sep 01, 2024

-0.28 / -0.19

-0.17

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?

These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:

Abbott Laboratories - Strong Buy, based on 20 analyst ratings, 17 Buy, 3 Hold, and 0 Sell.

Eli Lilly & Co - Strong Buy, based on 18 analyst ratings, 17 Buy, 1 Hold, and 0 Sell.

UnitedHealth - Strong Buy, based on 19 analyst ratings, 18 Buy, 1 Hold, and 0 Sell.

Are Healthcare stocks overpriced?

Pfizer's stock price is currently $25.61, and its average 12-month price target is $31.80.

Novartis's stock price is currently $105.03, and its average 12-month price target is $123.90.

Johnson & Johnson's stock price is currently $156.99, and its average 12-month price target is $177.75.

Roche Holding's stock price is currently $35.62, and its average 12-month price target is $42.50.

Abbott Laboratories's stock price is currently $117.12, and its average 12-month price target is $133.33.

Eli Lilly & Co's stock price is currently $753.36, and its average 12-month price target is $1,042.13.

CVS Health's stock price is currently $57.13, and its average 12-month price target is $67.36.

UnitedHealth's stock price is currently $597.03, and its average 12-month price target is $624.63.

Teladoc's stock price is currently $10.49, and its average 12-month price target is $10.91.

Which Healthcare stocks pay dividends?

Pfizer does not currently pay dividends.

Novartis does not currently pay dividends.

Johnson & Johnson currently pays a dividend of $1.24 which represents an annual dividend yield of 3.17%. Johnson & Johnson's next Ex-dividend date is November 26, 2024 and its next payout date is December 10, 2024.

Roche Holding does not currently pay dividends.

Abbott Laboratories does not currently pay dividends.

Eli Lilly & Co does not currently pay dividends.

CVS Health does not currently pay dividends.

UnitedHealth currently pays a dividend of $2.10 which represents an annual dividend yield of 1.38%. UnitedHealth's next Ex-dividend date is December 9, 2024 and its next payout date is December 17, 2024.

Teladoc does not currently pay dividends.